Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at

HIV Prevention Trials Network (HPTN)

The HIV Prevention Trials Network develops and tests the safety and efficacy of primarily non-vaccine interventions designed to prevent the transmission of HIV.

Main Areas of Focus

  • To discover and develop new and innovative research strategies to reduce the acquisition and transmission of HIV


The Executive Committee is made up of: Principal Investigators (PIs), International Lead Investigator, Past PI and Co-PI, SDMC PI & LC PI,  LOC Director, Community Representative, two NIH Representatives, and two Site Representatives.


HPTN has 90 clinical research sites in more than 15 countries around the world.


HPTN holds an annual meeting as well as regular regional meetings.

Content last reviewed on November 17, 2017